INSULET CORP (PODD)

US45784P1012 - Common Stock

266.57  +10.01 (+3.9%)

After market: 266.57 0 (0%)

Fundamental Rating

6

Taking everything into account, PODD scores 6 out of 10 in our fundamental rating. PODD was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While PODD has a great profitability rating, there are some minor concerns on its financial health. PODD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make PODD a good candidate for growth investing.



8

1. Profitability

1.1 Basic Checks

In the past year PODD was profitable.
PODD had a positive operating cash flow in the past year.
Each year in the past 5 years PODD has been profitable.
PODD had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 13.91%, PODD belongs to the top of the industry, outperforming 94.65% of the companies in the same industry.
With an excellent Return On Equity value of 37.65%, PODD belongs to the best of the industry, outperforming 98.93% of the companies in the same industry.
PODD's Return On Invested Capital of 8.69% is amongst the best of the industry. PODD outperforms 88.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PODD is below the industry average of 8.19%.
The last Return On Invested Capital (8.69%) for PODD is above the 3 year average (4.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.91%
ROE 37.65%
ROIC 8.69%
ROA(3y)3%
ROA(5y)2.07%
ROE(3y)10.71%
ROE(5y)9.71%
ROIC(3y)4.58%
ROIC(5y)3.92%

1.3 Margins

With an excellent Profit Margin value of 21.22%, PODD belongs to the best of the industry, outperforming 93.58% of the companies in the same industry.
PODD's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 15.42%, PODD belongs to the top of the industry, outperforming 85.56% of the companies in the same industry.
PODD's Operating Margin has improved in the last couple of years.
PODD has a better Gross Margin (69.36%) than 79.68% of its industry peers.
PODD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.42%
PM (TTM) 21.22%
GM 69.36%
OM growth 3Y31.55%
OM growth 5Y12.81%
PM growth 3Y152.86%
PM growth 5Y83.43%
GM growth 3Y2.01%
GM growth 5Y0.8%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PODD is destroying value.
PODD has more shares outstanding than it did 1 year ago.
PODD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PODD has an improved debt to assets ratio.

2.2 Solvency

PODD has an Altman-Z score of 7.16. This indicates that PODD is financially healthy and has little risk of bankruptcy at the moment.
PODD has a better Altman-Z score (7.16) than 84.49% of its industry peers.
PODD has a debt to FCF ratio of 6.41. This is a slightly negative value and a sign of low solvency as PODD would need 6.41 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.41, PODD is in the better half of the industry, outperforming 75.40% of the companies in the same industry.
A Debt/Equity ratio of 1.21 is on the high side and indicates that PODD has dependencies on debt financing.
PODD's Debt to Equity ratio of 1.21 is on the low side compared to the rest of the industry. PODD is outperformed by 79.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 6.41
Altman-Z 7.16
ROIC/WACC0.98
WACC8.84%

2.3 Liquidity

PODD has a Current Ratio of 3.68. This indicates that PODD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.68, PODD is in the better half of the industry, outperforming 66.31% of the companies in the same industry.
PODD has a Quick Ratio of 2.80. This indicates that PODD is financially healthy and has no problem in meeting its short term obligations.
PODD has a Quick ratio of 2.80. This is in the better half of the industry: PODD outperforms 60.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.68
Quick Ratio 2.8

8

3. Growth

3.1 Past

PODD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 129.49%, which is quite impressive.
Measured over the past years, PODD shows a very strong growth in Earnings Per Share. The EPS has been growing by 122.39% on average per year.
PODD shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.42%.
The Revenue has been growing by 24.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)129.49%
EPS 3Y104.08%
EPS 5Y122.39%
EPS Q2Q%26.76%
Revenue 1Y (TTM)27.42%
Revenue growth 3Y23.34%
Revenue growth 5Y24.66%
Sales Q2Q%25.7%

3.2 Future

Based on estimates for the next years, PODD will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.91% on average per year.
The Revenue is expected to grow by 16.93% on average over the next years. This is quite good.
EPS Next Y23.57%
EPS Next 2Y20.74%
EPS Next 3Y22.31%
EPS Next 5Y18.91%
Revenue Next Year24.75%
Revenue Next 2Y21.36%
Revenue Next 3Y20.02%
Revenue Next 5Y16.93%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 74.46 indicates a quite expensive valuation of PODD.
PODD's Price/Earnings ratio is a bit cheaper when compared to the industry. PODD is cheaper than 65.78% of the companies in the same industry.
PODD is valuated expensively when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 67.22 indicates a quite expensive valuation of PODD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PODD indicates a somewhat cheap valuation: PODD is cheaper than 67.91% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, PODD is valued quite expensively.
Industry RankSector Rank
PE 74.46
Fwd PE 67.22

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PODD indicates a somewhat cheap valuation: PODD is cheaper than 65.78% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PODD is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 85.69
EV/EBITDA 48.42

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of PODD may justify a higher PE ratio.
A more expensive valuation may be justified as PODD's earnings are expected to grow with 22.31% in the coming years.
PEG (NY)3.16
PEG (5Y)0.61
EPS Next 2Y20.74%
EPS Next 3Y22.31%

0

5. Dividend

5.1 Amount

No dividends for PODD!.
Industry RankSector Rank
Dividend Yield N/A

INSULET CORP

NASDAQ:PODD (12/20/2024, 8:00:00 PM)

After market: 266.57 0 (0%)

266.57

+10.01 (+3.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners101.43%
Inst Owner Change1.82%
Ins Owners2.39%
Ins Owner Change-0.76%
Market Cap18.70B
Analysts84.67
Price Target282.67 (6.04%)
Short Float %4.37%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.91%
Min EPS beat(2)-4.04%
Max EPS beat(2)15.85%
EPS beat(4)3
Avg EPS beat(4)51.21%
Min EPS beat(4)-4.04%
Max EPS beat(4)108.81%
EPS beat(8)7
Avg EPS beat(8)55.23%
EPS beat(12)10
Avg EPS beat(12)29.11%
EPS beat(16)12
Avg EPS beat(16)18.88%
Revenue beat(2)2
Avg Revenue beat(2)3.08%
Min Revenue beat(2)2.74%
Max Revenue beat(2)3.42%
Revenue beat(4)4
Avg Revenue beat(4)4.17%
Min Revenue beat(4)2.12%
Max Revenue beat(4)8.41%
Revenue beat(8)8
Avg Revenue beat(8)4.48%
Revenue beat(12)12
Avg Revenue beat(12)3.68%
Revenue beat(16)14
Avg Revenue beat(16)2.91%
PT rev (1m)11.91%
PT rev (3m)17.54%
EPS NQ rev (1m)0.86%
EPS NQ rev (3m)-17.57%
EPS NY rev (1m)6.9%
EPS NY rev (3m)8.84%
Revenue NQ rev (1m)1.13%
Revenue NQ rev (3m)1.97%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)2.04%
Valuation
Industry RankSector Rank
PE 74.46
Fwd PE 67.22
P/S 9.42
P/FCF 85.69
P/OCF 57.04
P/B 16.72
P/tB 19.34
EV/EBITDA 48.42
EPS(TTM)3.58
EY1.34%
EPS(NY)3.97
Fwd EY1.49%
FCF(TTM)3.11
FCFY1.17%
OCF(TTM)4.67
OCFY1.75%
SpS28.28
BVpS15.94
TBVpS13.78
PEG (NY)3.16
PEG (5Y)0.61
Profitability
Industry RankSector Rank
ROA 13.91%
ROE 37.65%
ROCE 12.15%
ROIC 8.69%
ROICexc 12.7%
ROICexgc 13.92%
OM 15.42%
PM (TTM) 21.22%
GM 69.36%
FCFM 11%
ROA(3y)3%
ROA(5y)2.07%
ROE(3y)10.71%
ROE(5y)9.71%
ROIC(3y)4.58%
ROIC(5y)3.92%
ROICexc(3y)7.16%
ROICexc(5y)6.49%
ROICexgc(3y)7.87%
ROICexgc(5y)7.13%
ROCE(3y)6.4%
ROCE(5y)5.48%
ROICexcg growth 3Y27.74%
ROICexcg growth 5Y14.31%
ROICexc growth 3Y27.45%
ROICexc growth 5Y14.17%
OM growth 3Y31.55%
OM growth 5Y12.81%
PM growth 3Y152.86%
PM growth 5Y83.43%
GM growth 3Y2.01%
GM growth 5Y0.8%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 6.41
Debt/EBITDA 3.53
Cap/Depr 140.33%
Cap/Sales 5.52%
Interest Coverage 250
Cash Conversion 85.34%
Profit Quality 51.84%
Current Ratio 3.68
Quick Ratio 2.8
Altman-Z 7.16
F-Score7
WACC8.84%
ROIC/WACC0.98
Cap/Depr(3y)204.22%
Cap/Depr(5y)305.15%
Cap/Sales(3y)9.88%
Cap/Sales(5y)14.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)129.49%
EPS 3Y104.08%
EPS 5Y122.39%
EPS Q2Q%26.76%
EPS Next Y23.57%
EPS Next 2Y20.74%
EPS Next 3Y22.31%
EPS Next 5Y18.91%
Revenue 1Y (TTM)27.42%
Revenue growth 3Y23.34%
Revenue growth 5Y24.66%
Sales Q2Q%25.7%
Revenue Next Year24.75%
Revenue Next 2Y21.36%
Revenue Next 3Y20.02%
Revenue Next 5Y16.93%
EBIT growth 1Y123.2%
EBIT growth 3Y62.26%
EBIT growth 5Y40.63%
EBIT Next Year152.91%
EBIT Next 3Y56.07%
EBIT Next 5Y41.4%
FCF growth 1Y446.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y665.89%
OCF growth 3Y20.15%
OCF growth 5Y32.33%